Clinical Trials on Non-hematologic Malignancies

Total 31646 results

Amgen

Completed

Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa

Anemia | Non-Myeloid Malignancies
The Catholic University of Korea

Unknown

Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation

Hematologic Malignancies

Korea, Republic of
Fate Therapeutics
Dana-Farber Cancer Institute

Completed

Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

Hematologic Malignancies | Allogeneic Stem Cell Transplantation

United States
Catherine Bollard
Johns Hopkins University; Children's National Research Institute

Recruiting

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

United States
Ottawa Hospital Research Institute

Not yet recruiting

Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies (SAD)

Secondary Antibody Deficiency
Duke University
Blue Spark Technologies

Not yet recruiting

VitalTraq for the Detection of CRS

Hematologic Malignancy
Massachusetts General Hospital
The Leukemia and Lymphoma Society

Recruiting

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Hematologic Malignancy | Bone Marrow Transplant Complications

United States
Aperture Medical Technology, LLC

Recruiting

A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy

Hematologic Malignancy

United States
Sofia Ramström

Enrolling by invitation

Function of Platelets Used for Transfusions

Thrombocytopenia | Hematologic Malignancy

Sweden
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Intervention for Fatigue in HCT Recipients

Hematologic Malignancy | Hematologic Cancer

United States
Dartmouth-Hitchcock Medical Center

Recruiting

Immune Profiling for Cancer Immunotherapy Response

Cancer | Hematologic Malignancy | Blood Cancer | Tumor, Solid

United States
Brigham and Women's Hospital
Harvard Medical School (HMS and HSDM)

Completed

A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients (PATH II)

Hematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood Cancer

United States
University of California, San Diego

Terminated

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme) (I-PREDICT Heme)

Hematologic Cancer

United States
M.D. Anderson Cancer Center

Recruiting

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Recruiting

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Hematologic Malignancies

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Hematologic Malignancies

United States
Jazz Pharmaceuticals
The Lymphoma Academic Research Organisation; EUSA SAS

Completed

Phase I Study of mPEG-R-Crisantaspase Given IV

Hematologic Malignancies

France
Kiadis Pharma

Completed

Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Hematologic Diseases | Hematologic Malignancies

Canada
Innovative Cellular Therapeutics Co., Ltd.

Unknown

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Lymphoma, B-Cell | Leukemia, B-Cell

China
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

China
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

Cancer | Solid Tumor | Hematologic Malignancy | Oral Drug Administration

Italy
Medical University of Vienna

Completed

Extended Analysis for Leukemia/Lymphoma Treatment (EXALT)

Relapsed Hematologic Malignancy

Austria
Emory University
Dana-Farber Cancer Institute; University of Massachusetts, Worcester

Completed

Mindfulness Meditation in Bone Marrow Transplantation

Stem Cell Transplantation | Bone Marrow Transplantation | Hematologic Malignancy

United States
Shenzhen TargetRx, Inc.
Institute of Hematology & Blood Diseases Hospital, China

Recruiting

TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Non Hodgkin Lymphoma | Hematologic Malignancy | Acute Lymphoblastic Leukemia, Adult

China
University of Chicago

Terminated

Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies

Hematologic Malignancies

United States
Indiana University School of Medicine
National Institutes of Health (NIH)

Withdrawn

In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells

Hematopoietic Stem Cell Transplantation | Hematologic Malignancies
Amgen

Completed

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Cancer | Non-Myeloid Malignancies
Roswell Park Cancer Institute

Recruiting

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

Hematopoietic and Lymphoid System Neoplasm

United States
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.

Recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

Hematologic Malignancies

China
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Exercise Prehab in Older Adults With Hematologic Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
St. Jude Children's Research Hospital
Michigan State University

Completed

Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors

Hematologic Malignancies

United States
Catholic University of the Sacred Heart
Pagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P

Completed

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant (HEMA E-CHART)

Stem Cell Transplantation | Hematological Malignancies

Italy
Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
Molecular Templates, Inc.

Terminated

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)

Leukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell Lymphoma

United States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
Biocity Biopharmaceutics Co., Ltd.

Recruiting

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

Hematologic Malignancy

China
Seagen Inc.

Completed

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin

United States
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)

China
Assistance Publique Hopitaux De Marseille

Unknown

Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies

Leukemia

France
University of Oklahoma

Completed

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice (PalliaQOL)

Hematologic Malignancy

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Solid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid Carcinoma

United States
iCell Gene Therapeutics
iCar Bio Therapeutics

Not yet recruiting

Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia

High Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid Leukemia

China
Pfizer

Completed

MEK162 for Patients With RAS/RAF/MEK Activated Tumors (SIGNATURE)

Solid Tumor and Hematologic Malignancies

United States
Peking University People's Hospital

Not yet recruiting

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Haematological Malignancy
Centre Henri Becquerel

Unknown

Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units (TEMPET)

Haematological Malignancy

France
M.D. Anderson Cancer Center
Genzyme, a Sanofi Company

Terminated

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

Lymphoma | Leukemia | Myelodysplastic Syndrome | Hematological Malignancies

United States
Assiut University

Unknown

Fungal Infections in Patients With Hematological Malignancies

Fungal Infection
AbbVie

Recruiting

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

Hematologic Malignancies

United States, Australia
Sidney Kimmel Cancer Center at Thomas Jefferson...

Recruiting

A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

Hematopoietic and Lymphoid Cell Neoplasm

United States
Genentech, Inc.

Completed

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors

Hematologic Malignancies | Tumors

Spain, France, United States, United Kingdom
Duke University

Completed

Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets

Hematologic Malignancies

United States

Clinical Trials on Non-hematologic Malignancies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations